Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery
- 1 August 1997
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 333 (2-3) , 191-197
- https://doi.org/10.1016/s0014-2999(97)01137-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bedBritish Journal of Pharmacology, 1997
- An Endogenous Cannabinoid as an Endothelium-Derived VasorelaxantBiochemical and Biophysical Research Communications, 1996
- Identification of Epoxyeicosatrienoic Acids as Endothelium-Derived Hyperpolarizing FactorsCirculation Research, 1996
- Formation and inactivation of endogenous cannabinoid anandamide in central neuronsNature, 1994
- Varying Extracellular [K+]Journal of Cardiovascular Pharmacology, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endotheliumNature, 1990
- Endothelium-derived hyperpolarizing a new endogenous inhibitor from the vascular endotheliumTrends in Pharmacological Sciences, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980